Article: Current use of intralesional cidofovir for recurrent respiratory papillomatosis
- Survey of 82 surgeons managing adult and pediatric RRP
- 18 consensus statements from the RRP task force
- Intralesional cidofovir- use if debulking is needed every 2-3 months
- Safe dosing of 3mg/kg
- Need for special consent, discussion of off-label use and AKI in pediatric patients